CAS 863288-34-0
CJC-1295 no DAC 5 mg
GHRH analogue (Mod GRF 1-29) studied in research on the somatotropic axis.
£38.99 In stockOften ordered with
Lyophilised peptides are reconstituted with a laboratory diluent. Add it to the same parcel.
Bacteriostatic water 10 ml£10.99
Normal price, no bundle discount.
- Dispatched from UK stock
- Royal Mail Tracked 48
- No customs or import VAT
- 6 certificates
- Plain packaging
- Bank transfer or crypto
For laboratory research only. Not suitable for human consumption or veterinary use.
Description
CJC-1295 without DAC (Mod GRF 1-29) is a short half-life analogue of growth hormone-releasing hormone, studied in laboratory models of the GH/IGF-1 axis. Research use only.
Specification
| CAS number | 863288-34-0 |
|---|---|
| Vial size | 5 mg |
| Purity | Specification ≥98%; the measured value is on the certificate of analysis for the lot |
| Molecular formula | C152H252N44O42 |
| Molar mass | 3367.9 g/mol |
| Sequence or identity | Modified GRF (1-29) |
| Form | Lyophilised powder |
| Research area | Somatotropic axis research |
| Storage | −20 °C, protected from light; after reconstitution, 2 to 8 °C |
Certificates of analysis
6 certificates from independent EU laboratories, newest first. The lot number is printed on your vial label.
Please note: these certificates were issued for 2 mg vials of this substance, not for the 5 mg vial sold on this page. They document the substance and the lot, not the filled quantity. For a certificate of the exact vial you received, write to us with the lot number from the label.
- Lot PO-20263315 mg vialOpen PDFAnalysed 13/07/2026 · Purity >99.8% · Liquilabs s.r.o.
- Lot 20252955 mg vialwith mannitolOpen PDFAnalysed 29/01/2026 · Purity >99.8% · Liquilabs s.r.o.
- Lot 20252955 mg vialOpen PDFAnalysed 29/01/2026 · Purity >99.8% · Liquilabs s.r.o.
- Lot 20252585 mg vialOpen PDFAnalysed 25/07/2025 · Purity >99.8% · Liquilabs s.r.o.
- Lot 20252472 mg vialwith mannitol, supersededOpen PDFAnalysed 15/04/2025 · Purity 98.17% · APIGENEX s.r.o.
- Lot 20241985 mg vialOpen PDFAnalysed 09/05/2024 · Purity 99.26% · APIGENEX s.r.o.
Every certificate we hold is in the certificate library.
Published research
- Jetté L et al. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology, 2005. PubMed 15817669 · doi:10.1210/en.2004-1286
Identified CJC-1295 as an albumin-binding hGRF(1-29) analogue resistant to DPP-IV that stimulates GH secretion in rats.
Published laboratory and preclinical research, cited for scientific context only. It is not evidence of safety or effect in people.
Documentation
Every vial ships with a written specification. More on how lots are tested: Quality and testing · What a certificate of analysis shows · How purity is measured.
Questions about CJC-1295 no DAC 5 mg
Is CJC-1295 no DAC 5 mg intended for human use?
No. CJC-1295 no DAC 5 mg is supplied exclusively for in vitro laboratory research. It is not a medicine, food supplement or cosmetic and must not be administered to people or animals.
What purity does CJC-1295 no DAC 5 mg have?
The specification is at least 98%. The latest lot with a measured value, PO-2026331, was analysed on 13/07/2026 by Liquilabs s.r.o. at >99.8%.
How should CJC-1295 no DAC 5 mg be stored?
At −20 °C, protected from light; after reconstitution, 2 to 8 °C.
How is CJC-1295 no DAC 5 mg shipped?
From UK stock by Royal Mail Tracked 48, in plain packaging, once payment has arrived. Royal Mail aims to deliver in 2 to 3 working days. Free delivery from £25.
Related products
